Integr-algal

整体藻类

• 批准号: 131909
• 金额: $ 11.95万
• 依托单位: ALGAECYTES LIMITED
• 依托单位国家: 英国
• 项目类别: Feasibility Studies
• 财政年份: 2015
• 资助国家: 英国
• 起止时间: 2015 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=131909
• 关键词: Integr; algal

This project addresses the challenge of intensifying phototrophic algal production of high value natural products by integrating the it with downstream processing (extraction of Omega 3s from Algae). The aim is to produce high value Omega-3 polyunsaturated fatty acids (PUFAs), for use as active pharmaceutical ingredients (APIs) or food supplements. The novel process will, if successful, result in continuous growth of the algae, product formation and recovery. The new process will provide a commercially viable alternative to the extraction of PUFAs from fish, thus helping to provide a sustainable source for vegetarian consumers. The incorporation of Omega-3s (EPA and docosahexaenoic acid – DHA) into diet is relevant to the UK Government’s strategy for well-being and maintaining the health of an increasingly aging UK population. The aging population in developing countries and dwindling oily fish supplies will mean a growing market for alternative sources of Omega 3 (EPA) in the next 25 years.

该项目通过将其与下游加工（从藻类中提取Omega 3s）相结合，解决了加强高价值天然产品的光合藻类生产的挑战。目的是生产高价值的Omega-3多不饱和脂肪酸（PUFA），用作活性药物成分（API）或食品补充剂。如果成功的话，这种新方法将导致藻类的连续生长、产品的形成和回收。新工艺将为从鱼类中提取PUFA提供商业上可行的替代方案，从而有助于为素食消费者提供可持续的来源。将欧米茄-3脂肪酸（EPA和二十二碳六烯酸- DHA）纳入饮食与英国政府的福祉和保持日益老龄化的英国人口健康的战略有关。发展中国家的人口老龄化和油性鱼类供应的减少将意味着未来25年欧米茄3（EPA）替代来源的市场不断增长。